<DOC>
	<DOCNO>NCT01606709</DOCNO>
	<brief_summary>The purpose study compare gene expression profile endometrial biopsy window implantation trigger oocyte maturation use GnRH agonist hCG compare natural cycle order identify gene may dysregulated GnRH agonist-triggered cycle . The investigator also intend evaluate patient feel well physical quality life GnRH agonist trigger compare hCG trigger</brief_summary>
	<brief_title>Gene Expression Profile After Gonadotropin Releasing Hormone ( GnRH ) Agonist Trigger Oocyte Maturation</brief_title>
	<detailed_description>Ovarian hyperstimulation syndrome ( OHSS ) iatrogenic complication control ovarian hyperstimulation ( COH ) may result significant morbidity rarely mortality well significant financial psychological distress . The use GnRH agonist induction final oocyte maturation ovarian stimulation cycle utilize GnRH antagonist pituitary suppression proven effective method prevent risk OHSS development . Unfortunately , study , , also report low pregnancy rate cycle compare cycle use hCG trigger attribute possible impaired endometrial receptivity . The investigator intend obtain endometrial biopsy collect subject natural cycle biopsy either GnRH agonist hCG trigger stimulation . Expression profile mRNAs first screen use microarray technology . Relative level specific mRNAs display alter expression GnRH-triggered sample , assayed microarray , confirm real-time , quantitative reverse transcription/polymerase chain reaction ( Q-PCR ) . The investigator shall also evaluate patient feel well physical quality life GnRH agonist trigger compare hCG trigger .</detailed_description>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Oocyte donor Ages 21 33 Normal baseline serum FSH &lt; 10mIU/mL Hypothalamic dysfunction Smokers Baseline serum FSH â‰¥ 10mIU/mL</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>33 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>GnRHa trigger</keyword>
	<keyword>endometrial gene profile</keyword>
	<keyword>quality life</keyword>
</DOC>